Buys
Open market- Shares
- +488,090
- Avg price
- $25.61
- Total value
- +$12,499,985
ARCH Venture Fund XIII, L.P. - 10%+ Owner at Lyell Immunopharma, Inc.
Insider Transactions and Holdings
- Entity type
- Company
- Role
- 10%+ Owner
- Issuer symbol
- LYEL on Nasdaq
- Source filings
- Open source filing history
Identity
Issuer context
SEC evidence
ARCH Venture Fund XIII, L.P. - trading volume in the past year for Lyell Immunopharma, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +488,090
- Share %
- 100%
- Total value
- +$12,499,985
Holdings reported by ARCH Venture Fund XIII, L.P. for Lyell Immunopharma, Inc.
Form 4 holding
10%+ Owner
Lyell Immunopharma, Inc.
- Security class
- Common Stock
- Shares / value
- 1,426,528
- Estimated value
- $36,533,382
- Report date
- 06 Mar 2026
- Price
- $25.61
- Ownership
- Indirect
Transactions reported by ARCH Venture Fund XIII, L.P. for Lyell Immunopharma, Inc.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.